Computed Tomography–Based Biomarker Outcomes in a Prospective Trial of Preoperative FOLFIRINOX and Chemoradiation for Borderline Resectable Pancreatic Cancer

PURPOSE: Effective preoperative regimens and biomarkers for pancreatic ductal adenocarcinoma (PDAC) are lacking. We prospectively evaluated fluorouracil, leucovorin, irinotecan, and oxaliplatin (FOLFIRINOX)-based treatment and imaging-based biomarkers for borderline resectable PDAC. METHODS: Eligibl...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JCO Precis Oncol
Autors principals: Koay, Eugene J., Katz, Matthew H.G., Wang, Huamin, Wang, Xuemei, Prakash, Laura, Javle, Milind, Shroff, Rachna, Fogelman, David, Avila, Santiago, Zaid, Mohamed, Elganainy, Dalia, Lee, Yeonju, Crane, Christopher H., Krishnan, Sunil, Das, Prajnan, Fleming, Jason B., Lee, Jeffrey E., Tamm, Eric P., Bhosale, Priya, Lee, Jeffrey H., Weston, Brian, Maitra, Anirban, Wolff, Robert A., Varadhachary, Gauri R.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Clinical Oncology 2019
Matèries:
Original Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7446521/
https://ncbi.nlm.nih.gov/pubmed/32914036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/PO.19.00001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars